SCHEMBL7419503

SCHEMBL7419503

N#CC1(N(Cc2ccc(F)cc2)C(=O)[CH]CC2(C(N)=O)CCCCC2)CCNC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.32
ALDH1A1 P00352 1/20 0.31
NSD2 O96028 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416951 0.91
SCHEMBL6371523 0.91 SNCA (0.33)
SCHEMBL7422302 0.87 SLC6A2 (0.35)
SCHEMBL7573990 0.86
SCHEMBL7420829 0.85 SNCA (0.34) ALDH1A1
SCHEMBL7416244 0.84 GPR132 (0.31) ALDH1A1
SCHEMBL7014387 0.84 SNCA (0.33) ALDH1A1
SCHEMBL7418232 0.82 PTGES (0.35)
SCHEMBL7411437 0.82 CTSB (0.31)
SCHEMBL7414438 0.81 PTGES (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed